130 related articles for article (PubMed ID: 8634830)
21. Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at alpha 1 and alpha 2 adrenergic receptors.
DeBernardis JF; Kyncl JJ; Basha FZ; Arendsen DL; Martin YC; Winn M; Kerkman DJ
J Med Chem; 1986 Apr; 29(4):463-7. PubMed ID: 2870187
[TBL] [Abstract][Full Text] [Related]
22. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
23. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
[TBL] [Abstract][Full Text] [Related]
24. [Imidazoline-guanidine site: a subtype of imidazoline receptors].
Coupry I; Limon I; Tesson F; Lachaud V; Gargalidis-Moudanos C; Parini A
Therapie; 1992 Nov; 47(6):519-24. PubMed ID: 1338740
[TBL] [Abstract][Full Text] [Related]
25. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
Zonnenchein R; Diamant S; Atlas D
Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
[TBL] [Abstract][Full Text] [Related]
26. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex.
Tesson F; Parini A
Eur J Pharmacol; 1991 Sep; 208(1):81-3. PubMed ID: 1936130
[TBL] [Abstract][Full Text] [Related]
27. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
28. Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors.
Raasch W; Chun KRJ ; Dendorfer A; Dominiak P
Jpn J Pharmacol; 2000 Sep; 84(1):1-6. PubMed ID: 11043446
[TBL] [Abstract][Full Text] [Related]
29. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
30. No evidence for functional imidazoline receptors on locus coeruleus neurons.
Szabo B; Fröhlich R; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
[TBL] [Abstract][Full Text] [Related]
31. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
32. The imidazoline-guanidinium receptor site, a target for some alpha-2 adrenergic agonists, is involved in inhibition of Na(+)-H+ exchange in renal proximal tubule cells.
Bidet M; Poujeol P; Parini A
J Hypertens Suppl; 1991 Dec; 9(6):S216-7. PubMed ID: 1687868
[No Abstract] [Full Text] [Related]
33. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
Mukaddam-Daher S; Lambert C; Gutkowska J
Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
[TBL] [Abstract][Full Text] [Related]
34. Further characterization of the guinea pig cerebral cortex idazoxan receptor: solubilization, distinction from the imidazole site, and demonstration of cirazoline as an idazoxan receptor-selective drug.
Wikberg JE; Uhlén S
J Neurochem; 1990 Jul; 55(1):192-203. PubMed ID: 1972387
[TBL] [Abstract][Full Text] [Related]
35. Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.
Horie K; Obika K; Foglar R; Tsujimoto G
Br J Pharmacol; 1995 Sep; 116(1):1611-8. PubMed ID: 8564227
[TBL] [Abstract][Full Text] [Related]
36. RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.
Brown CM; MacKinnon AC; Redfern WS; Williams A; Linton C; Stewart M; Clague RU; Clark R; Spedding M
Br J Pharmacol; 1995 Sep; 116(2):1737-44. PubMed ID: 8528553
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney.
Limon I; Coupry I; Lanier SM; Parini A
J Biol Chem; 1992 Oct; 267(30):21645-9. PubMed ID: 1400475
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
39. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
